Ionis Pharmaceuticals Inc (IONS)
43.10
+0.09
(+0.21%)
USD |
NASDAQ |
May 02, 16:00
43.11
+0.01
(+0.02%)
Pre-Market: 20:00
Ionis Pharmaceuticals Total Return Level: 43.10 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 43.10 |
May 01, 2024 | 43.01 |
April 30, 2024 | 41.26 |
April 29, 2024 | 41.99 |
April 26, 2024 | 41.59 |
April 25, 2024 | 41.84 |
April 24, 2024 | 42.45 |
April 23, 2024 | 41.84 |
April 22, 2024 | 41.07 |
April 19, 2024 | 40.68 |
April 18, 2024 | 40.81 |
April 17, 2024 | 40.91 |
April 16, 2024 | 41.54 |
April 15, 2024 | 41.55 |
April 12, 2024 | 41.74 |
April 11, 2024 | 42.50 |
April 10, 2024 | 42.94 |
April 09, 2024 | 42.83 |
April 08, 2024 | 42.24 |
April 05, 2024 | 43.22 |
April 04, 2024 | 42.83 |
April 03, 2024 | 43.78 |
April 02, 2024 | 43.00 |
April 01, 2024 | 43.94 |
March 28, 2024 | 43.35 |
Date | Value |
---|---|
March 27, 2024 | 44.66 |
March 26, 2024 | 44.11 |
March 25, 2024 | 43.91 |
March 22, 2024 | 42.72 |
March 21, 2024 | 42.75 |
March 20, 2024 | 42.78 |
March 19, 2024 | 42.16 |
March 18, 2024 | 42.03 |
March 15, 2024 | 42.55 |
March 14, 2024 | 42.18 |
March 13, 2024 | 43.16 |
March 12, 2024 | 43.17 |
March 11, 2024 | 43.26 |
March 08, 2024 | 43.99 |
March 07, 2024 | 44.67 |
March 06, 2024 | 44.29 |
March 05, 2024 | 44.19 |
March 04, 2024 | 44.87 |
March 01, 2024 | 45.46 |
February 29, 2024 | 45.21 |
February 28, 2024 | 46.54 |
February 27, 2024 | 47.41 |
February 26, 2024 | 46.10 |
February 23, 2024 | 45.36 |
February 22, 2024 | 43.98 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
25.61
Minimum
Dec 01 2021
73.46
Maximum
May 03 2019
46.53
Average
44.10
Median
Aug 12 2022
Total Return Level Benchmarks
Madrigal Pharmaceuticals Inc | 216.11 |
Viking Therapeutics Inc | 75.76 |
Alnylam Pharmaceuticals Inc | 150.31 |
Akero Therapeutics Inc | 19.69 |
89bio Inc | 8.86 |